curasan AG: Bioactive bone regeneration material approved for sale in Europe

22-Oct-2010 - Germany

curasan AG has received European approval for its new granular bone regeneration material Ceracell®.

Hans Dieter Rössler, CEO of curasan AG, considers the CE-certification of Ceracell® to be another milestone in the implementation of the product offensive launched at the beginning of the year: “We are implementing our strategy of offering innovative biomaterials, customized to the needs of the users, both consistently and persistently. The launch of Ceracell® in the dental market is planned to coincide with the world’s largest international dental exhibition in Cologne (IDS) at the end of March next year, and it will be launched approximately three months later in the orthopaedic market.”

Other news from the department research and development

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance